APA

Sennels H., Sørensen S., Ostergaard M., Knudsen L., Hansen M., Skjødt H., Peters N., Colic A., Grau K. & Jacobsen S. (20081016). Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate. : Scandinavian journal of rheumatology.

Chicago

Sennels Hp, Sørensen S, Ostergaard M, Knudsen Ls, Hansen Ms, Skjødt H, Peters Nd, Colic A, Grau K and Jacobsen S. 20081016. Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate. : Scandinavian journal of rheumatology.

Harvard

Sennels H., Sørensen S., Ostergaard M., Knudsen L., Hansen M., Skjødt H., Peters N., Colic A., Grau K. and Jacobsen S. (20081016). Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate. : Scandinavian journal of rheumatology.

MLA

Sennels Hp, Sørensen S, Ostergaard M, Knudsen Ls, Hansen Ms, Skjødt H, Peters Nd, Colic A, Grau K and Jacobsen S. Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate. : Scandinavian journal of rheumatology. 20081016.